Therabiopharma Inc. focuses on the development of CMG as a drug for various refractory cancers with/without other approved cancer drugs. In particular, it has a strong focus for treatment/drug resistant cancers with multiple mutations of genes.

← Return to Japanese Biotech Company Announces 10,000 Times Higher Curcumin Concentration in Bloodstream Clearly Demonstrates Strong Efficacies with/without Oxaliplatin for Colon Cancer

Therabiopharma Inc. focuses on the development of CMG as a drug for various refractory cancers with/without other approved cancer drugs. In particular, it has a strong focus for treatment/drug resistant cancers with multiple mutations of genes.

By JAPAN PRODUCTS | Uploaded 08/23/2018 | Full size is 1744 × 1047 pixels

$Therabiopharma Inc. focuses on the development of CMG as a drug for various refractory cancers with/without other approved cancer drugs. In particular, it has a strong focus for treatment/drug resistant cancers with multiple mutations of genes.$